Document is current
Any future updates will be listed below
-
Authors
Haddad, Jihad A. https://orcid.org/0000-0001-5936-9986
Annabi, Firas O. Abbas
Abbasi, Hiba
AlSamen, Muneer A. Abu
Ammari, Fawaz L.
Haddad, Fares H.
Haddad, Suhair E.
Jaradat, Mustafa
Khassawneh, Adi
Khatib, Nidal
Magableh, Arabieh
Al-Mousa, Eyas
-
Funding
Funding for this research was provided by:
Novo Nordisk
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 26 February 2025
First Online: 19 March 2025
Declarations
:
: Firas O. Abbas Annabi, Hiba Abbasi, Muneer A. Abu AlSamen, Eyas N. Al-Mousa, Fawaz L. Ammari, Jihad A. Haddad, Mustafa Jaradat, Adi Khassawneh, Nidal Khatib, Fares H. Haddad have no conflicts of interest to declare. Suhair E. Haddad and Arabieh Magableh are employees of, and own stock in, Novo Nordisk.
: The study protocol and informed consent form were reviewed and approved by the local institutional review board/ethics committee and other regulatory agencies, as required for each participating country. In Jordan, the study protocol was reviewed by the Institutional Review Board at Jordan University of Science and Technology and approved on 25 May 2022 (reference number 2022/148/79) and by the Institutional Review Board at Jordan University Hospital and approved on 8 June 2022 (reference number 2022/177).
